Anika Therapeutics, Inc. Operating Income
Anika Therapeutics, Inc. (ANIK) reported Operating Income of $2.95 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-07-29
- Anika Therapeutics, Inc. operating income (loss) for the quarter ending 2026-06-30 was $2.95M.
- Anika Therapeutics, Inc. operating income (loss) for the quarter ending 2026-03-31 was -$5.49M.
- Anika Therapeutics, Inc. operating income (loss) for the quarter ending 2025-12-31 was $646.00K.
- Anika Therapeutics, Inc. operating income (loss) for the quarter ending 2025-09-30 was -$3.23M.
- Anika Therapeutics, Inc. operating income (loss) for fiscal 2025 was -$11.05M.
- Anika Therapeutics, Inc. operating income (loss) for fiscal 2024 was -$5.10M, a 704.38% decline from fiscal 2023.
- Anika Therapeutics, Inc. operating income (loss) for fiscal 2023 was $844.00K, a 77.00% decline from fiscal 2022.
- Anika Therapeutics, Inc. operating income (loss) for fiscal 2022 was $3.67M, a 40.34% increase from fiscal 2021.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.95M 10-Q · filed 2026-07-29 | -$2.53M 10-Q · filed 2026-07-29 | -$1.89M derived: sum of 3 quarters · filed 2026-07-29 | -$5.12M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2026-03-31 | -$5.49M 10-Q · filed 2026-04-30 | -$4.84M derived: sum of 2 quarters · filed 2026-04-30 | -$8.07M derived: sum of 3 quarters · filed 2026-04-30 | -$12.26M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-12-31 | $646.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$2.59M derived: sum of 2 quarters · filed 2026-03-03 | -$6.77M derived: sum of 3 quarters · filed 2026-07-29 | -$11.05M 10-K · filed 2026-03-03 | ||||
| 2025-09-30 | -$3.23M 10-Q · filed 2025-11-05 | -$7.41M derived: sum of 2 quarters · filed 2026-07-29 | -$11.70M 10-Q · filed 2025-11-05 | -$12.40M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-06-30 | -$4.18M 10-Q · filed 2026-07-29 | -$8.46M 10-Q · filed 2026-07-29 | -$9.17M derived: sum of 3 quarters · filed 2026-07-29 | -$9.25M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-03-31 | -$4.28M 10-Q · filed 2026-04-30 | -$4.99M derived: sum of 2 quarters · filed 2026-04-30 | -$5.07M derived: sum of 3 quarters · filed 2026-04-30 | -$6.88M derived: sum of 4 quarters · filed 2026-04-30 | ||||
| 2024-12-31 | -$705.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$786.00K derived: sum of 2 quarters · filed 2026-03-03 | -$2.60M derived: sum of 3 quarters · filed 2026-03-03 | -$5.10M 10-K · filed 2026-03-03 | ||||
| 2024-09-30 | -$81.00K 10-Q · filed 2025-11-05 | -$28.02M 10-Q · filed 2024-11-04 | -$1.89M derived: sum of 2 quarters · filed 2025-11-05 | -$4.40M 10-Q · filed 2025-11-05 | -$32.92M 10-Q · filed 2024-11-04 | $20.31M derived: sum of 4 quarters · filed 2026-03-03 | ||
| 2024-06-30 | -$1.81M 10-Q · filed 2025-07-30 | $161.00K 10-Q · filed 2024-08-08 | -$4.32M 10-Q · filed 2025-07-30 | -$4.90M 10-Q · filed 2024-08-08 | $20.39M derived: sum of 3 quarters · filed 2026-03-03 | $12.71M derived: sum of 4 quarters · filed 2026-03-03 | ||
| 2024-03-31 | -$2.50M 10-Q · filed 2025-05-09 | -$5.06M 10-Q · filed 2024-05-08 | $22.20M derived: sum of 2 quarters · filed 2026-03-03 | $14.52M derived: sum of 3 quarters · filed 2026-03-03 | $10.89M derived: sum of 4 quarters · filed 2026-03-03 | |||
| 2023-12-31 | $24.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $17.03M derived: sum of 2 quarters · filed 2026-03-03 | $13.40M derived: sum of 3 quarters · filed 2026-03-03 | $844.00K 10-K · filed 2026-03-03 | -$87.64M 10-K · filed 2024-03-15 | |||
| 2023-09-30 | -$7.67M 10-Q · filed 2024-11-04 | -$11.30M derived: sum of 2 quarters · filed 2024-11-04 | -$23.86M 10-Q · filed 2024-11-04 | -$7.46M derived: sum of 4 quarters · filed 2025-03-17 | ||||
| 2023-06-30 | -$3.63M 10-Q · filed 2024-08-08 | -$16.18M 10-Q · filed 2024-08-08 | $219.00K derived: sum of 3 quarters · filed 2025-03-17 | -$5.58M derived: sum of 4 quarters · filed 2025-03-17 | ||||
| 2023-03-31 | -$12.55M 10-Q · filed 2024-05-08 | $3.85M derived: sum of 2 quarters · filed 2025-03-17 | -$1.95M derived: sum of 3 quarters · filed 2025-03-17 | -$5.33M derived: sum of 4 quarters · filed 2025-03-17 | ||||
| 2022-12-31 | $16.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $10.61M derived: sum of 2 quarters · filed 2025-03-17 | $7.22M derived: sum of 3 quarters · filed 2025-03-17 | $3.67M 10-K · filed 2025-03-17 | -$19.40M 10-K · filed 2023-03-16 | |||
| 2022-09-30 | -$5.80M 10-Q · filed 2023-11-03 | -$9.18M derived: sum of 2 quarters · filed 2023-11-03 | -$12.73M 10-Q · filed 2023-11-03 | -$21.86M derived: sum of 4 quarters · filed 2024-03-15 | ||||
| 2022-06-30 | -$3.38M 10-Q · filed 2023-08-08 | -$6.93M 10-Q · filed 2023-08-08 | -$16.06M derived: sum of 3 quarters · filed 2024-03-15 | -$14.76M derived: sum of 4 quarters · filed 2024-03-15 | ||||
| 2022-03-31 | -$3.55M 10-Q · filed 2023-05-09 | -$12.68M derived: sum of 2 quarters · filed 2024-03-15 | -$11.38M derived: sum of 3 quarters · filed 2024-03-15 | -$2.20M derived: sum of 4 quarters · filed 2024-03-15 | ||||
| 2021-12-31 | -$9.12M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | -$7.82M derived: sum of 2 quarters · filed 2024-03-15 | $1.36M derived: sum of 3 quarters · filed 2024-03-15 | $2.62M 10-K · filed 2024-03-15 | ||||
| 2021-09-30 | $1.30M 10-Q · filed 2022-11-09 | $10.48M derived: sum of 2 quarters · filed 2022-11-09 | $11.74M 10-Q · filed 2022-11-09 | -$6.21M derived: sum of 4 quarters · filed 2023-03-16 | ||||
| 2021-06-30 | $9.18M 10-Q · filed 2022-08-04 | $10.44M 10-Q · filed 2022-08-04 | -$7.51M derived: sum of 3 quarters · filed 2023-03-16 | -$15.44M derived: sum of 4 quarters · filed 2023-03-16 | ||||
| 2021-03-31 | $1.26M 10-Q · filed 2022-05-06 | -$16.70M derived: sum of 2 quarters · filed 2023-03-16 | -$24.62M derived: sum of 3 quarters · filed 2023-03-16 | -$34.16M derived: sum of 4 quarters · filed 2023-03-16 | ||||
| 2020-12-31 | -$17.95M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$25.88M derived: sum of 2 quarters · filed 2023-03-16 | -$35.42M derived: sum of 3 quarters · filed 2023-03-16 | -$28.32M 10-K · filed 2023-03-16 | ||||
| 2020-09-30 | -$7.93M 10-Q · filed 2021-11-05 | -$17.46M derived: sum of 2 quarters · filed 2021-11-05 | -$10.37M 10-Q · filed 2021-11-05 | -$5.57M derived: sum of 4 quarters · filed 2022-03-11 | ||||
| 2020-06-30 | -$9.54M 10-Q · filed 2021-08-06 | -$2.44M 10-Q · filed 2021-08-06 | $2.36M derived: sum of 3 quarters · filed 2022-03-11 | $14.41M derived: sum of 4 quarters · filed 2022-03-11 | ||||
| 2020-03-31 | $7.09M 10-Q · filed 2021-05-07 | $11.90M derived: sum of 2 quarters · filed 2022-03-11 | $23.95M derived: sum of 3 quarters · filed 2022-03-11 | $35.86M derived: sum of 4 quarters · filed 2022-03-11 | ||||
| 2019-12-31 | $4.80M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $16.85M derived: sum of 2 quarters · filed 2022-03-11 | $28.77M derived: sum of 3 quarters · filed 2022-03-11 | $34.25M 10-K · filed 2022-03-11 | ||||
| 2019-09-30 | $12.05M 10-Q · filed 2020-11-05 | $23.96M derived: sum of 2 quarters · filed 2020-11-05 | $29.45M 10-Q · filed 2020-11-05 | $39.21M derived: sum of 4 quarters · filed 2021-04-26 | ||||
| 2019-06-30 | $11.91M 10-Q · filed 2020-08-07 | $17.40M 10-Q · filed 2020-08-07 | $27.16M derived: sum of 3 quarters · filed 2021-04-26 | $35.73M derived: sum of 4 quarters · filed 2021-04-26 | ||||
| 2019-03-31 | $5.48M 10-Q · filed 2020-05-22 | $15.24M derived: sum of 2 quarters · filed 2021-04-26 | $23.82M derived: sum of 3 quarters · filed 2021-04-26 | $35.06M derived: sum of 4 quarters · filed 2021-04-26 | ||||
| 2018-12-31 | $9.76M derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-26 | $18.34M derived: sum of 2 quarters · filed 2021-04-26 | $29.58M derived: sum of 3 quarters · filed 2021-04-26 | $21.75M 10-K/A · filed 2021-04-26 | ||||
| 2018-09-30 | $8.57M 10-Q · filed 2019-10-28 | $19.82M derived: sum of 2 quarters · filed 2019-10-28 | $11.99M 10-Q · filed 2019-10-28 | $21.71M derived: sum of 4 quarters · filed 2020-03-06 | ||||
| 2018-06-30 | $11.25M 10-Q · filed 2019-07-26 | $3.41M 10-Q · filed 2019-07-26 | $13.14M derived: sum of 3 quarters · filed 2020-03-06 | $23.41M derived: sum of 4 quarters · filed 2020-03-06 | ||||
| 2018-03-31 | -$7.83M 10-Q · filed 2019-05-06 | $1.90M derived: sum of 2 quarters · filed 2020-03-06 | $12.16M derived: sum of 3 quarters · filed 2020-03-06 | $29.89M derived: sum of 4 quarters · filed 2020-03-06 | ||||
| 2017-12-31 | $9.73M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06 | $20.00M derived: sum of 2 quarters · filed 2020-03-06 | $37.72M derived: sum of 3 quarters · filed 2020-03-06 | $45.73M 10-K · filed 2020-03-06 | ||||
| 2017-09-30 | $10.27M 10-Q · filed 2018-10-26 | $28.00M derived: sum of 2 quarters · filed 2018-10-26 | $36.00M 10-Q · filed 2018-10-26 | $48.74M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-06-30 | $17.73M 10-Q · filed 2018-07-31 | $25.73M 10-Q · filed 2018-07-31 | $38.47M derived: sum of 3 quarters · filed 2019-02-27 | $52.16M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-03-31 | $8.01M 10-Q · filed 2018-05-10 | $20.75M derived: sum of 2 quarters · filed 2019-02-27 | $34.44M derived: sum of 3 quarters · filed 2019-02-27 | $47.90M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2016-12-31 | $12.74M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $26.43M derived: sum of 2 quarters · filed 2019-02-27 | $39.90M derived: sum of 3 quarters · filed 2019-02-27 | $50.61M 10-K · filed 2019-02-27 | ||||
| 2016-09-30 | $13.69M 10-Q · filed 2017-10-27 | $27.16M derived: sum of 2 quarters · filed 2017-10-27 | $37.87M 10-Q · filed 2017-10-27 | $54.93M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-06-30 | $13.47M 10-Q · filed 2017-07-28 | $24.18M 10-Q · filed 2017-07-28 | $41.24M derived: sum of 3 quarters · filed 2018-02-27 | $54.38M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-03-31 | $10.71M 10-Q · filed 2017-05-04 | $27.77M derived: sum of 2 quarters · filed 2018-02-27 | $40.91M derived: sum of 3 quarters · filed 2018-02-27 | $53.34M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2015-12-31 | $17.07M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $30.20M derived: sum of 2 quarters · filed 2018-02-27 | $42.63M derived: sum of 3 quarters · filed 2018-02-27 | $48.13M 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | $13.13M 10-Q · filed 2016-11-01 | $13.14M 10-Q · filed 2015-11-03 | $25.56M derived: sum of 2 quarters · filed 2016-11-01 | $31.07M 10-Q · filed 2016-11-01 | $31.07M 10-Q · filed 2015-11-03 | $43.16M derived: sum of 4 quarters · filed 2017-02-24 | ||
| 2015-06-30 | $12.43M 10-Q · filed 2016-08-01 | $12.43M 10-Q · filed 2015-08-04 | $17.93M 10-Q · filed 2016-08-01 | $17.93M 10-Q · filed 2015-08-04 | $30.02M derived: sum of 3 quarters · filed 2017-02-24 | $40.31M derived: sum of 4 quarters · filed 2017-02-24 | ||
| 2015-03-31 | $5.50M 10-Q · filed 2016-05-03 | $5.50M 10-Q · filed 2015-05-04 | $17.59M derived: sum of 2 quarters · filed 2017-02-24 | $27.88M derived: sum of 3 quarters · filed 2017-02-24 | $43.08M derived: sum of 4 quarters · filed 2017-02-24 | |||
| 2014-12-31 | $12.09M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $22.37M derived: sum of 2 quarters · filed 2017-02-24 | $37.58M derived: sum of 3 quarters · filed 2017-02-24 | $61.45M 10-K · filed 2017-02-24 | $61.45M 10-K · filed 2015-03-13 | |||
| 2014-09-30 | $10.29M 10-Q · filed 2015-11-03 | $25.49M derived: sum of 2 quarters · filed 2015-11-03 | $49.36M 10-Q · filed 2015-11-03 | $59.79M derived: sum of 4 quarters · filed 2016-03-10 | ||||
| 2014-06-30 | $15.20M 10-Q · filed 2015-08-04 | $39.07M 10-Q · filed 2015-08-04 | $49.50M derived: sum of 3 quarters · filed 2016-03-10 | $57.27M derived: sum of 4 quarters · filed 2016-03-10 | ||||
| 2014-03-31 | $23.87M 10-Q · filed 2015-05-04 | $34.30M derived: sum of 2 quarters · filed 2016-03-10 | $42.07M derived: sum of 3 quarters · filed 2016-03-10 | $51.47M derived: sum of 4 quarters · filed 2016-03-10 | ||||
| 2013-12-31 | $10.43M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $18.20M derived: sum of 2 quarters · filed 2016-03-10 | $27.60M derived: sum of 3 quarters · filed 2016-03-10 | $32.61M 10-K · filed 2016-03-10 | $32.61M 10-K · filed 2014-03-13 | |||
| 2013-09-30 | $7.77M 10-Q · filed 2014-11-06 | $17.16M derived: sum of 2 quarters · filed 2014-11-06 | $22.18M 10-Q · filed 2014-11-06 | $29.97M derived: sum of 4 quarters · filed 2015-03-13 | ||||
| 2013-06-30 | $9.40M 10-Q · filed 2014-08-04 | $14.41M 10-Q · filed 2014-08-04 | $22.20M derived: sum of 3 quarters · filed 2015-03-13 | $24.93M derived: sum of 4 quarters · filed 2015-03-13 | ||||
| 2013-03-31 | $5.01M 10-Q · filed 2014-05-05 | $12.80M derived: sum of 2 quarters · filed 2015-03-13 | $15.53M derived: sum of 3 quarters · filed 2015-03-13 | $21.66M derived: sum of 4 quarters · filed 2015-03-13 | ||||
| 2012-12-31 | $7.79M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $10.52M derived: sum of 2 quarters · filed 2015-03-13 | $16.65M derived: sum of 3 quarters · filed 2015-03-13 | $19.72M 10-K · filed 2015-03-13 | ||||
| 2012-09-30 | $2.73M 10-Q · filed 2013-11-05 | $8.86M derived: sum of 2 quarters · filed 2013-11-05 | $11.92M 10-Q · filed 2013-11-05 | $16.84M derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2012-06-30 | $6.13M 10-Q · filed 2013-08-06 | $9.20M 10-Q · filed 2013-08-06 | $14.11M derived: sum of 3 quarters · filed 2014-03-13 | $18.93M derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2012-03-31 | $3.06M 10-Q · filed 2013-05-06 | $7.98M derived: sum of 2 quarters · filed 2014-03-13 | $12.80M derived: sum of 3 quarters · filed 2014-03-13 | $16.47M derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2011-12-31 | $4.92M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | $9.73M derived: sum of 2 quarters · filed 2014-03-13 | $13.41M derived: sum of 3 quarters · filed 2014-03-13 | $13.97M 10-K · filed 2014-03-13 | ||||
| 2011-09-30 | $4.82M 10-Q · filed 2012-11-08 | $8.49M derived: sum of 2 quarters · filed 2012-11-08 | $9.05M 10-Q · filed 2012-11-08 | $11.53M derived: sum of 4 quarters · filed 2013-03-14 | ||||
| 2011-06-30 | $3.68M 10-Q · filed 2012-08-07 | $4.23M 10-Q · filed 2012-08-07 | $6.71M derived: sum of 3 quarters · filed 2013-03-14 | $8.79M derived: sum of 4 quarters · filed 2013-03-14 | ||||
| 2011-03-31 | $556.68K 10-Q · filed 2012-05-07 | $3.03M derived: sum of 2 quarters · filed 2013-03-14 | $5.11M derived: sum of 3 quarters · filed 2013-03-14 | $6.92M derived: sum of 4 quarters · filed 2013-03-14 | ||||
| 2010-12-31 | $2.48M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | $4.56M derived: sum of 2 quarters · filed 2013-03-14 | $6.36M derived: sum of 3 quarters · filed 2013-03-14 | $7.54M 10-K · filed 2013-03-14 | ||||
| 2010-09-30 | $2.08M 10-Q · filed 2011-11-04 | $3.88M derived: sum of 2 quarters · filed 2011-11-04 | $5.06M 10-Q · filed 2011-11-04 | |||||
| 2010-06-30 | $1.80M 10-Q/A · filed 2011-08-10 | $2.98M 10-Q/A · filed 2011-08-10 | ||||||
| 2009-12-31 | $5.59M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |